Microreaction System Nears Launch
News Aug 15, 2007
Uniqsis Ltd., the Cambridge-based company formed in January 2007 to develop a new concept in microreaction flow chemistry has announced major progress towards launching FlowSyn™ later in the year.
Martyn Fordham, CEO said “Development of FlowSyn, our new fully integrated flow reaction platform, is entering its final phase. Pre-production units are already undergoing evaluation in-house and in several pharmaceutical and academic laboratories around the UK.
FlowSyn will be introduced to the scientific community and the technical press at an event we are hosting in early October, with workshops and presentations from leading scientists in the field.”
Fordham also announced that the Uniqsis team has been strengthened by the arrival of Dr. Otman Benali from GSK’s Technology Development department, where he has been working on enabling technologies to speed up drug discovery processes, with a major focus on Microreaction Technology (MRT).
He was involved in validating most of the commercially available flow chemistry equipment and brings that invaluable experience to Uniqsis to guide the FlowSyn engineering team.
According to Benali “Micro reactors have distinct advantages over batch processes. They offer improved mixing and heat transfer which leads to excellent reproducibility. Scale-up becomes much easier, with less re-optimisation, and fewer problems with unstable intermediates or highly exothermic reactions.
It’s also easier to add additional features such as on-line analysis or pressurization. Most fine chemical companies are aware of these benefits and were interested in its implementation when I joined GSK in 2002 but there was then no suitable commercial instrumentation available.
We’re confident that FlowSyn will be a useful tool for the chemist. Because it is a new technology, training and information exchange will be a key element of our plans to help users capitalise on its benefits.”
Uniqsis Ltd. is an alliance between Asynt, the specialist supplier of organic synthesis apparatus, and Grant Instruments (Cambridge) Ltd., the long established scientific equipment manufacturer.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018